152 related articles for article (PubMed ID: 36080060)
1. Amphiphilic Cationic Peptide-Coated PHA Nanosphere as an Efficient Vector for Multiple-Drug Delivery.
Zhang F; Zhang C; Fu S; Liu H; Han M; Fan X; Zhang H; Li W
Nanomaterials (Basel); 2022 Aug; 12(17):. PubMed ID: 36080060
[TBL] [Abstract][Full Text] [Related]
2. Affibody Modified G-quadruplex DNA Micelles Incorporating Polymeric 5-Fluorodeoxyuridine for Targeted Delivery of Curcumin to Enhance Synergetic Therapy of HER2 Positive Gastric Cancer.
Zhang C; Fu S; Zhang F; Han M; Wang X; Du J; Zhang H; Li W
Nanomaterials (Basel); 2022 Feb; 12(4):. PubMed ID: 35215023
[TBL] [Abstract][Full Text] [Related]
3. Affibody-Conjugated RALA Polymers Delivering Oligomeric 5-Fluorodeoxyuridine for Targeted Therapy of HER2 Overexpressing Gastric Cancer.
Zhang F; Yin J; Zhang C; Han M; Wang X; Fu S; Du J; Zhang H; Li W
Macromol Biosci; 2020 Jul; 20(7):e2000083. PubMed ID: 32558229
[TBL] [Abstract][Full Text] [Related]
4. The improvement of fibroblast growth on hydrophobic biopolyesters by coating with polyhydroxyalkanoate granule binding protein PhaP fused with cell adhesion motif RGD.
Dong Y; Li P; Chen CB; Wang ZH; Ma P; Chen GQ
Biomaterials; 2010 Dec; 31(34):8921-30. PubMed ID: 20728212
[TBL] [Abstract][Full Text] [Related]
5. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
6. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
[TBL] [Abstract][Full Text] [Related]
7. Graft copolymer nanoparticles with pH and reduction dual-induced disassemblable property for enhanced intracellular curcumin release.
Zhao J; Liu J; Xu S; Zhou J; Han S; Deng L; Zhang J; Liu J; Meng A; Dong A
ACS Appl Mater Interfaces; 2013 Dec; 5(24):13216-26. PubMed ID: 24313273
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene glycol) crosslinked multi-armed poly(ε-benzyloxycarbonyl-L-lysine)s as super-amphiphiles: Synthesis, self-assembly, and evaluation as efficient delivery systems for poorly water-soluble drugs.
Lu C; Jiang L; Xu W; Yu F; Xia W; Pan M; Zhou W; Pan X; Wu C; Liu D
Colloids Surf B Biointerfaces; 2019 Oct; 182():110384. PubMed ID: 31357126
[TBL] [Abstract][Full Text] [Related]
9. Synergistically enhanced anticancer effect of codelivered curcumin and siPlk1 by stimuli-responsive α-lactalbumin nanospheres.
Li D; Shi M; Bao C; Bao W; Zhang L; Jiao L; Li T; Li Y
Nanomedicine (Lond); 2019 Mar; 14(5):595-612. PubMed ID: 30806584
[TBL] [Abstract][Full Text] [Related]
10. Redox responsive xylan-SS-curcumin prodrug nanoparticles for dual drug delivery in cancer therapy.
Sauraj ; Vinay Kumar ; Kumar B; Priyadarshi R; Deeba F; Kulshreshtha A; Kumar A; Agrawal G; Gopinath P; Negi YS
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110356. PubMed ID: 31761247
[TBL] [Abstract][Full Text] [Related]
11. Amifostine-conjugated pH-sensitive calcium phosphate-covered magnetic-amphiphilic gelatin nanoparticles for controlled intracellular dual drug release for dual-targeting in HER-2-overexpressing breast cancer.
Li WM; Chiang CS; Huang WC; Su CW; Chiang MY; Chen JY; Chen SY
J Control Release; 2015 Dec; 220(Pt A):107-118. PubMed ID: 26478017
[TBL] [Abstract][Full Text] [Related]
12. Core-shell pea protein-carboxymethylated corn fiber gum composite nanoparticles as delivery vehicles for curcumin.
Wei Y; Cai Z; Wu M; Guo Y; Wang P; Li R; Ma A; Zhang H
Carbohydr Polym; 2020 Jul; 240():116273. PubMed ID: 32475561
[TBL] [Abstract][Full Text] [Related]
13. Calcium phosphate coated core-shell protein nanocarriers: Robust stability, controlled release and enhanced anticancer activity for curcumin delivery.
Wu Q; Gao H; Vriesekoop F; Liu Z; He J; Liang H
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111094. PubMed ID: 32600698
[TBL] [Abstract][Full Text] [Related]
14. Amphiphilic PHA-mPEG copolymeric nanocontainers for drug delivery: preparation, characterization and in vitro evaluation.
Shah M; Naseer MI; Choi MH; Kim MO; Yoon SC
Int J Pharm; 2010 Nov; 400(1-2):165-75. PubMed ID: 20713137
[TBL] [Abstract][Full Text] [Related]
15. Animal protein-plant protein composite nanospheres for dual-drug loading and synergistic cancer therapy.
Lu M; Wu M; Huang Y; Yao J; Shao Z; Chen X
J Mater Chem B; 2022 May; 10(20):3798-3807. PubMed ID: 35416829
[TBL] [Abstract][Full Text] [Related]
16. Concanavaline A conjugated bacterial polyester-based PHBHHx nanoparticles loaded with curcumin for breast cancer therapy.
Kilicay E; Karahaliloglu Z; Hazer B; Tekin IÖ; Denkbas EB
J Microencapsul; 2016 May; 33(3):274-85. PubMed ID: 27049468
[TBL] [Abstract][Full Text] [Related]
17. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
18. Novel Dual Mitochondrial and CD44 Receptor Targeting Nanoparticles for Redox Stimuli-Triggered Release.
Wang K; Qi M; Guo C; Yu Y; Wang B; Fang L; Liu M; Wang Z; Fan X; Chen D
Nanoscale Res Lett; 2018 Feb; 13(1):32. PubMed ID: 29396830
[TBL] [Abstract][Full Text] [Related]
19. Preparation of polyhydroxyalkanoate-based magnetic microspheres for carbonyl reductase purification and immobilization.
Han M; Li X; Wang X; Liu D; Fu S; Xu W; Li W; Zhang H
Int J Biol Macromol; 2023 Dec; 253(Pt 4):126814. PubMed ID: 37690644
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Effect of Self-Assembled Curcumin and Piperine Co-Loaded Human Serum Albumin Nanoparticles on Suppressing Cancer Cells.
Abolhassani H; Safavi MS; Handali S; Nosrati M; Shojaosadati SA
Drug Dev Ind Pharm; 2020 Oct; 46(10):1647-1655. PubMed ID: 32892656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
